Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 162

Similar articles for PubMed (Select 23663404)

1.

The influence of Apolipoprotein E genotype on regional pathology in Alzheimer's disease.

Sabbagh MN, Malek-Ahmadi M, Dugger BN, Lee K, Sue LI, Serrano G, Walker DG, Davis K, Jacobson SA, Beach TG.

BMC Neurol. 2013 May 11;13:44. doi: 10.1186/1471-2377-13-44.

2.

Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status.

Malek-Ahmadi M, Beach T, Obradov A, Sue L, Belden C, Davis K, Walker DG, Lue L, Adem A, Sabbagh MN.

Curr Alzheimer Res. 2013 Jul;10(6):654-9.

3.

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM.

Arch Neurol. 1998 Mar;55(3):326-35.

PMID:
9520006
4.

Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.

Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW.

Lancet Neurol. 2011 Sep;10(9):785-96. doi: 10.1016/S1474-4422(11)70156-9. Epub 2011 Jul 27.

5.

Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians.

Morris CM, Benjamin R, Leake A, McArthur FK, Candy JM, Ince PG, Torvik A, Bjertness E, Edwardson JA.

Neurosci Lett. 1995 Dec 1;201(1):45-7.

PMID:
8830309
6.

Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.

Small GW, Siddarth P, Burggren AC, Kepe V, Ercoli LM, Miller KJ, Lavretsky H, Thompson PM, Cole GM, Huang SC, Phelps ME, Bookheimer SY, Barrio JR.

Arch Gen Psychiatry. 2009 Jan;66(1):81-7. doi: 10.1001/archgenpsychiatry.2008.516.

7.

Genetic polymorphisms in sigma-1 receptor and apolipoprotein E interact to influence the severity of Alzheimer's disease.

Huang Y, Zheng L, Halliday G, Dobson-Stone C, Wang Y, Tang HD, Cao L, Deng YL, Wang G, Zhang YM, Wang JH, Hallupp M, Kwok J, Chen SD.

Curr Alzheimer Res. 2011 Nov;8(7):765-70.

PMID:
21605063
8.

APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy.

Tsuboi Y, Josephs KA, Cookson N, Dickson DW.

Neurology. 2003 Jan 28;60(2):240-5.

PMID:
12552038
9.

Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.

Lim AS, Yu L, Kowgier M, Schneider JA, Buchman AS, Bennett DA.

JAMA Neurol. 2013 Dec;70(12):1544-51. doi: 10.1001/jamaneurol.2013.4215.

11.

APOE, vascular pathology, and the AD brain.

Yip AG, McKee AC, Green RC, Wells J, Young H, Cupples LA, Farrer LA.

Neurology. 2005 Jul 26;65(2):259-65.

PMID:
16043796
12.

Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.

Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J.

Neurology. 2004 Jun 8;62(11):1977-83.

PMID:
15184600
13.

Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype.

Lippa CF, Smith TW, Saunders AM, Hulette C, Pulaski-Salo D, Roses AD.

Neurology. 1997 Feb;48(2):515-9.

PMID:
9040748
14.

Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.

Davidson Y, Gibbons L, Pritchard A, Hardicre J, Wren J, Tian J, Shi J, Stopford C, Julien C, Thompson J, Payton A, Thaker U, Hayes AJ, Iwatsubo T, Pickering-Brown SM, Pendleton N, Horan MA, Burns A, Purandare N, Lendon CL, Neary D, Snowden JS, Mann DM.

J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):515-7.

15.

[Expression of apolipoprotein E in Alzheimer's disease and its significance].

He SR, Liu DG, Wang S, Xia YJ.

Zhonghua Bing Li Xue Za Zhi. 2005 Sep;34(9):556-60. Chinese.

PMID:
16468304
16.

Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.

Tian J, Shi J, Bailey K, Lendon CL, Pickering-Brown SM, Mann DM.

J Neurol Neurosurg Psychiatry. 2004 May;75(5):696-9.

17.

Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype.

Conejero-Goldberg C, Hyde TM, Chen S, Dreses-Werringloer U, Herman MM, Kleinman JE, Davies P, Goldberg TE.

Mol Psychiatry. 2011 Aug;16(8):836-47. doi: 10.1038/mp.2010.57. Epub 2010 May 18.

18.
19.

APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer's disease.

Donix M, Burggren AC, Scharf M, Marschner K, Suthana NA, Siddarth P, Krupa AK, Jones M, Martin-Harris L, Ercoli LM, Miller KJ, Werner A, von Kummer R, Sauer C, Small GW, Holthoff VA, Bookheimer SY.

Psychiatry Res. 2013 Dec 30;214(3):212-20. doi: 10.1016/j.pscychresns.2013.09.006. Epub 2013 Sep 27.

20.

Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.

Nagy Z, Esiri MM, Jobst KA, Johnston C, Litchfield S, Sim E, Smith AD.

Neuroscience. 1995 Dec;69(3):757-61.

PMID:
8596645
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk